ToddWRidkyMDPh.D.

Dermatology • Philadelphia, PA

Assoc. Professor, Dermatology, Perelman School of Medicine

Join to view full profile

Dr. Ridky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ridky's full profile

Already have an account?

Office
3400 Civic Center Blvd
1330S Perelman Center
Philadelphia, PA 19104
Phone+1 215-662-2737

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 2000 - 2003
The MetroHealth System/Case Western Reserve UniversityInternship, Internal Medicine, 1999 - 2000
Case Western Reserve University School of MedicineClass of 1999

Certifications & Licensure

CA State Medical License 2000 - Present
PA State Medical License 2010 - 2024
OH State Medical License 1999 - 2000
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

66 citations
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma
Andrew S. McNeal, Kevin Liu, Vihang Nakhate, Christopher A. Natale, Elizabeth K. Duperret
Cancer Discovery. 2015-07-16
378 citations
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.
Vladimir Ratushny, Michael D. Gober, Ryan Hick, Todd W. Ridky, John T. Seykora
The Journal of Clinical Investigation. 2012-02-01
11 citations
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression.
Jaskaren Kohli, Chen Ge, Eleni Fitsiou, Miriam Doepner, Simone M Brandenburg
Nature Communications. 2022-12-23

Press Mentions

Researchers Find DOPA May Protect Against Melanoma and Identify Potential New Therapeutic Targets to Treat MelanomaSeptember 8th, 2022
Prostate Cancer Drugs Could Be Effectively Repurposed to Inhibit Melanoma in MenOctober 27th, 2021
Viral Infection of Human Neurons Triggers Strain-Specific Differences in Host Neuronal and Viral TranscriptomesMarch 22nd, 2021
Join now to see all

Grant Support

Physiologic Function Of RAS Effectors MEK 1/2 On Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
Physiologic Function Of RAS Effectors MEK 1/2 On Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2010
RAS Dependent Human Cutaneous NeoplasiaNational Cancer Institute2003–2005